$AORT News

Artivion (NYSE:AORT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Artivion Bets On Full Aortic Arch Suite After Endospan Deal

Artivion closes Endospan buyout to acquire recently approved heart device

Artivion strengthens aortic arch portfolio with $135m Endospan acquisition

Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System

Artivion Completes Acquisition of Endospan Ltd.

5 Insightful Analyst Questions From Artivion’s Q1 Earnings Call

Artivion Inc (NYSE:AORT) Catches the GARP Eye With Affordable Growth Screen

Artivion (AORT) Price Target Decreased by 16.86% to 43.73

Artivion, Inc. 2026 Q1 - Results - Earnings Call Presentation

Why Artivion (AORT) Stock Is Falling Today

AORT Q1 Deep Dive: Guidance Reset and Product Launches Shape 2026 Outlook

How Artivion’s Softer 2026 Outlook After Q1 Profit Turn Will Impact Artivion (AORT) Investors

Artivion, Inc. (AORT) Q1 2026 Earnings Call Transcript

Artivion Q1 Earnings Call Highlights

Citizens Maintains Market Outperform on Artivion, Lowers Price Target to $48

Needham Maintains Buy on Artivion, Lowers Price Target to $44

Artivion Inc (NYSE:AORT) Stock Slides After Q1 Revenue Miss Despite Earnings Beat

Artivion (AORT) Q1 Earnings and Revenues Surpass Estimates

Artivion (AORT) Q1 2026 Earnings Transcript